Skip to content

Public FDA record

Z-0809-04: RETi-LOCK Cluster-Hole Acetabular Shells with Sealed Screw-holes manufactured by Zimmer, Austin, Texas

Recall record Z-0809-04 for Centerpulse Orthopedics, Inc. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0809-04
Company in FDA record
Centerpulse Orthopedics, Inc
FDA classification date
Jul 20, 2004
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 20, 2026
Recall classification
Unknown — no matched enforcement classification

Reason stated in the source

Compalints of acetabular shell disassociating with the bone.

Source facts

Action
The firm called and issued letters on September 30, 2003 informing physicians of a complaint received. The letter requested that the physicians discontinue use of the device until and investigation could be conducted. On 03/8/2004 the firm issued a letter to Zimmer distributors to return all inventory.
Initiated
2003-09-30
Root cause
Other
Terminated
2004-11-04
Distribution
Physicians in the following areas: CA, Washington D.C., MD, LA, ID, and WA
Recall number
Z-0809-04
Recall status
Terminated
CDRH record ID
32028
FDA classified
2004-07-20
Recall event number
28512

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗